M&A Deal Summary |
|
---|---|
Date | 2023-10-17 |
Target | Ironstone Product Development |
Sector | Medical Products |
Buyer(s) | Avania |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1988 |
Sector | Medical Products |
Employees | 271 |
Avania is an integrated global, full-service CRO with specialized expertise in medical devices, novel technology, and combination products. It advances products from feasibility all the way through post-approval trials in analytics, clinical trials, consulting, regulatory, reimbursement, and more. Avania was founded in 1988 and is based in Boston, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 4 of 5 |
Sector (Medical Products) | 2 of 2 |
Type (Add-on Acquisition) | 4 of 5 |
State (Ontario) | 1 of 1 |
Country (Canada) | 1 of 1 |
Year (2023) | 3 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-10-17 |
Hull Associates
Rockland, Massachusetts, United States Hull Associates is a strategic market access and reimbursement consultancy firm specialized in achieving market access for medical device, diagnostic, and specialty pharma products in all major global markets, including United States, Europe, Latin America, Japan, India, and China. Hull Associates was founded in 2007 and is based in Rockland, Massachusetts. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-10-08 |
Anagram
Barcelona, Spain Anagram is a Clinical Research Organization (CRO) based in Spain providing clinical development and post-authorization trials for drugs and medical devices. Services include image central reading (core lab), analysis, and reporting by highly experienced professionals. It has specialized expertise in cardiology, neurology, and oncology. Anagram was formed in 1998 and is based in Barcelona. |
Buy | - |